Aging populations will lead to a growing number of active epilepsy diagnoses

Datamonitor has estimated that there were approximately 4.5 million cases of diagnosed active epilepsy in 2010 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). Almost half of this patient population lives in the US. Datamonitor expects prevalence rates to remain constant over the forecast period (2010–20).

Datamonitor expects an increase in diagnosed active epilepsy cases in the next decade in the seven major markets as a result of an increase in populations.

Chronic epilepsy can result in brain damage, disability, and a low quality of life causing high social and economic burden.

Read more...

Comments

Add New Search RSS

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
	Please input the anti-spam code that you can read in the image.

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• Epilepsy (01/07/2011)
• Epilepsy (01/07/2011)
• Potiga (01/07/2011)

• Global Health Care Equipment (16/11/2011)
• OTC (25/07/2011)
• mHealth and Telemedicine (06/07/2011)

• Pharmaceutical Excipients (30/06/2011)
• Cardiovascular and Metabolic Market (15/06/2011)
• Outsourcing (15/06/2011)
• NORMAL TOOTH PASTE VS HERBAL TOOTH PASTE (09/05/2011)
• Regenerative Medicine (03/05/2011)
• Biosimilar Market Overview (24/03/2011)
• Archiving of Medical Images (01/02/2011)
• Emerging Markets and Drug Discovery (28/01/2011)
• U.S. Biopharmaceutical Market (06/12/2010)

---